NMD-VCell Neuromuscular Virtual Cell Research Platform Module: Models · Evidence → perturbation → experiment → outcome NMD = neuromuscular disorders

Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible

View scientific status
Evidence freeze: 3 August 2026 Resource: v1.2.0-measured-dmd-evidence Schema: 1.1 Open release status →

Model Card Audit

Gene–chemical bridge model

This card states exactly what the model was allowed to learn, predict, evaluate and claim in this release. Architecture labels and external publications do not create local DMD prediction performance.

NMDVCELL-GENE-CHEMICAL-BRIDGE-FUTURElocked not trained or not executed

Input, output and current result

InputRequired matched genetic and chemical screens in relevant muscle or DMD states
OutputDesired cross-modality response, mechanism concordance and uncertainty
Training context
No matched DMD genetic–chemical screen
Held-out task
Planned unseen compound · gene · donor · disease state
Current result
No drug-response or gene-to-compound translation is emitted.
Permitted use
Future design contract only

Audit axes

The model is reviewed across twelve required axes.

No scalar model score
Permanent baselines
  • nearest-neighbour
  • pathway mean
  • additive transfer
Primary metrics
  • retrieval
  • response similarity
  • calibration
  • prospective hit rate
Leakage control

registered_requirement_no_executed_split

Calibration / OOD

not_calibrated_for_dmd_response · not_validated_for_dmd_muscle_or_patient_context

Claim boundary

What this model card does not authorize

Unlock rule: Import traceable dose, time, target-engagement and phenotype truth for both modalities. Automatic unlock is disabled.